Sonorous Neurovascular Receives FDA IDE Approval for First U.S. Pivotal Trial of a Venous Sinus Stent to Treat Pulsatile Tinnitus
LAKE FOREST, Calif., Oct. 7, 2026 /PRNewswire/ — Sonorous Neurovascular, a clinical-stage medical device company […]
LAKE FOREST, Calif., Oct. 7, 2026 /PRNewswire/ — Sonorous Neurovascular, a clinical-stage medical device company […]
BLOOMINGTON, Minn., Oct. 6, 2026 /PRNewswire/ — Saluda Medical, Inc. (ASX: SLD, “Saluda” or the […]
Medtronic (NYSE:MDT) has secured a breakthrough designation from the FDA for a version of its […]
NEW YORK, Sept. 29, 2026 /PRNewswire/ — UTR Therapeutics Inc., a biotech company with clinical […]
As the race to harness CAR-T cells for autoimmune diseases hits a rough patch, a […]
MINNEAPOLIS, Sept. 24, 2026 /PRNewswire/ — Maternal health technology company Marani Health today announced that […]
The FDA cleared a personalized wound dressing that users can apply themselves at home following […]
TAMPA, Fla., Sept. 15, 2026 /PRNewswire/ — Applied Photonix today announced the commercial launch of ViroZap®, the first FDA-cleared, […]
CINCINNATI, Sept. 9, 2026 /PRNewswire/ — A new clinical support tool called Anatool aims to provide point-of-care […]
GUANGZHOU, China, Aug. 27, 2026 /PRNewswire/ — Guangzhou Rongtao Medical Technology Co., Ltd. (“Rongtao Medical”) today published an evidence-based […]
BURLINGTON, N.C., Aug. 24, 2026 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced […]
The FDA granted de novo classification to a standalone robotic device that can draw blood […]
The FDA published a discussion paper this week seeking feedback on its considerations for regulations […]
MINNEAPOLIS, Aug. 11, 2026 /PRNewswire/ — FastWave Medical, which is developing next-generation intravascular lithotripsy (IVL) technology, has received FDA approval of […]
ALACHUA, Fla., Aug. 10, 2026 /PRNewswire/ — Amend Surgical, a regenerative biomaterials company focused on developing innovative […]
SALT LAKE CITY, Aug. 6, 2026 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (“Co-Dx” or “the Company”), a molecular diagnostics company with […]
Adagio Medical (Nasdaq:ADGM) today announced the successful treatment of the first patient with its next-generation vCLAS […]
VDyne announced today that it enrolled the first patient in the pivotal FDA investigational device exemption […]
Glaukos (NYSE:GKOS) announced today that it completed enrollment in a pivotal study evaluating its Preserflo MicroShunt […]
Johnson & Johnson (NYSE:JNJ) announced today that it received FDA de novo authorization for its Ottava […]
Claria Medical announced today that it received FDA de novo authorization for its Claria system […]
xDot Medical announced today that it received FDA investigational device exemption (IDE) approval for its […]
ROTTERDAM, Netherlands and SAN DIEGO, July 1, 2026 /PRNewswire/ — SkylineDx, innovative diagnostics company specializing in the […]
Aurenar announced today that it received FDA breakthrough device designation for its V-Link noninvasive neuromodulation […]
Johnson & Johnson (NYSE:JNJ) today announced the initiation of its SKYWARD clinical program for a new Shockwave IVL […]
RAMAT GAN, Israel, June 24, 2026 /PRNewswire/ — Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, […]
AngioDynamics (Nasdaq:ANGO) announced today that it received FDA investigational device exemption (IDE) to initiate the RELIEF […]
TORONTO, June 9, 2026 /PRNewswire/ – SpinaFX Medical, a clinical-stage medical device company specializing in minimally invasive, […]
ST. PAUL, Minn., June 3, 2026 /PRNewswire/ — Zepto Life Technology announced today that the U.S. Food […]
Neurovalens announced today that it received FDA de novo approval for Modius Spero, a post-traumatic stress […]
Adagio Medical (Nasdaq:ADGM) announced today that it submitted its premarket approval (PMA) application to the FDA […]
Zimmer Biomet (NYSE:ZBH) announced today that it received FDA 510(k) clearance for an advanced version of […]
Dive Brief: Dive Insight: Researchers have linked the presence of circulating tumor DNA, or ctDNA, […]
Zenflow recently shared data from its BREEZE pivotal clinical trial supporting the use of its Spring […]
Resmed (NYSE: RMD) has entered into a definitive merger agreement to acquire Noctrix Health for $340 […]
CAMBRIDGE, UK, April 29, 2026 — CMR Surgical, a global medical technology business, today announced that […]
Pixee Medical announced today that it received FDA 510(k) clearance for its Knee+ NexSight augmented reality […]
Medtronic (NYSE:MDT) today announced new milestones for its Affera family of technologies, including a breakthrough device […]
Adagio Medical (Nasdaq:ADGM) today announced new six-month results from its FULCRUM-VT clinical trial evaluating its ablation […]